Elaine Cheung - Lyell
bm-navigation: bm-t3-home-navigation
bm-pageheader: bm-t3-pageheader

Elaine Cheung

Senior Vice President, Corporate Strategy & Business Development

Elaine Cheung

Elaine_Cheung_Senior_Vice_President_Business_DevelopmentElaine brings to Lyell over 20 years of business experience in the life sciences, focused on corporate & business development, strategy, and operations.

Elaine spent most of her career to date advancing products and strategies in clinical genomics, beginning at Genomic Health (now Exact Sciences), where she focused on growing the company’s OncoType Dx™ product portfolio in multiple disease indications, and international commercial expansion. She then joined Illumina in 2012, where she was the business development lead for Illumina’s Oncology Business Unit and executed the company’s OncoPanel transactions with AstraZeneca, Janssen, Merck KGaA, and Sanofi Aventis. While at Illumina, Elaine also developed and executed strategies in the fields of Rare and Undiagnosed Genetic Disease (NGS-based WGS for diagnosis of rare genetic conditions in neonates), Non-Invasive Prenatal Testing (including Illumina’s acquisition of Verinata) and Transplant Medicine/HLA typing for bone marrow transplant applications. Finally, she led the spin-out efforts of GRAIL from Illumina in 2016.

As a founding employee and Head of Business Development at GRAIL, Elaine implemented the partnerships that enabled large scale clinical trials, and the strategic pharma collaborations and investments that comprised a major portion of GRAIL’s record-breaking $900M+ Series B financing.

Immediately prior to joining Lyell, Elaine was a VP at Mindstrong Health, a digital healthcare company focused on improving clinical outcomes in severe mental illness utilizing touchscreen-based digital biomarkers. There, she oversaw operations, communications and marketing/policy.

Elaine earned a B.S. in Biological Sciences and an M.S. in Management Science & Engineering, both from Stanford University, where she was also a Mayfield Fund Fellow.